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a b s t r a c t
Transforming growth factor-beta3 (TGF-β3) plays a critical role in palatal epithelial cells by inducing
palatal epithelial fusion, failure of which results in cleft palate, one of the most common birth defects in
humans. Recent studies have shown that Smad-dependent and Smad-independent pathways work
redundantly to transduce TGF-β3 signaling in palatal epithelial cells. However, detailed mechanisms by
which this signaling is mediated still remain to be elucidated. Here we show that TGF-β activated kinase-
1 (Tak1) and Smad4 interact genetically in palatal epithelial fusion. While simultaneous abrogation of
both Tak1 and Smad4 in palatal epithelial cells resulted in characteristic defects in the anterior and
posterior secondary palate, these phenotypes were less severe than those seen in the corresponding
Tgfb3 mutants. Moreover, our results demonstrate that Trim33, a novel chromatin reader and regulator
of TGF-β signaling, cooperates with Smad4 during palatogenesis. Unlike the epithelium-speciﬁc Smad4
mutants, epithelium-speciﬁc Tak1:Smad4- and Trim33:Smad4-double mutants display reduced expres-
sion of Mmp13 in palatal medial edge epithelial cells, suggesting that both of these redundant
mechanisms are required for appropriate TGF-β signal transduction. Moreover, we show that inactiva-
tion of Tak1 in Trim33:Smad4 double conditional knockouts leads to the palatal phenotypes which are
identical to those seen in epithelium-speciﬁc Tgfb3 mutants. To conclude, our data reveal added
complexity in TGF-β signaling during palatogenesis and demonstrate that functionally redundant
pathways involving Smad4, Tak1 and Trim33 regulate palatal epithelial fusion.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Cleft palate, one of the most common birth defects in humans,
is caused by a failure in palatogenesis (Chai and Maxson, 2006).
During mammalian development, the secondary palate, which
separates the oral cavity from the nasal cavity, develops as
bilateral outgrowths (palatal shelves) of the maxillary processes
of the ﬁrst pharyngeal arch (Bush and Jiang, 2012). Palatal shelves
ﬁrst grow vertically down along the sides of the tongue; then they
rapidly elevate and fuse in the midline (Ferguson, 1987). Failure in
any of these three processes can result in cleft palate. The palatal
shelf growth and patterning are governed by complex interactions
between the ectoderm-derived epithelium, and the underlying
mesenchyme derived from the cranial neural crest. One of the later
events in palatogenesis, albeit a critical one, is epithelial fusion.
During this process, the medial edge epithelium (MEE) in tips of
the opposing palatal shelves ﬁrst forms the midline seam, which
subsequently disappears. Many studies, both in humans and mice,
have shown that signaling initiated by TGF-β3 is required for
successful epithelial fusion (Dudas et al., 2007).
TGF-β3 binds and activates a heterotetrameric receptor com-
plex composed of two type II and two type I receptors. Ligand-
receptor interactions result in phosphorylation of TGF-β R-Smads
2 and 3 and subsequent complex formation with a common Smad
(Co-Smad or Smad4). R-Smad/Co-Smad complexes then accumu-
late in the nucleus, where they function as transcriptional co-
regulators (Shi and Massague, 2003). This so called canonical (or
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Smad-dependent) signaling is regulated by many proteins inter-
acting either with receptor complexes or Smads, e.g., SARA, Axin,
inhibitory Smads (I-Smads) and Trim33 (Derynck and Zhang,
2003; Lamouille et al., 2014; Massague and Xi, 2012). Previous
studies have shown that Trim33 (Tif1γ, ectodermin) may regulate
TGF-β superfamily signaling in different ways depending on the
biological context. Dupont et al. suggested that Trim33 is a
negative regulator of TGF-β signaling by functioning as a mono-
ubiquitin ligase capable of disrupting activated R-Smad/Co-Smad
complexes, while He et al. showed that Trim33 can bind to
activated R-Smads in competition with Smad4 and mediate dis-
tinct TGF-β signaling processes (He et al., 2006). It also has been
suggested that Trim33/R-Smad complexes can function as chro-
matin readers by making target genes accessible to R-Smad/Co-
Smad complexes or by controlling the time the Smad complexes
are bound to promoter sequences. In addition to the canonical
(Smad-dependent) pathway, TGF-βs can also trigger non-
canonical (Smad-independent) signaling processes leading to
activation of various downstream mediators, such as small rho-
related GTPases, TGF-β-activated kinase-1 and downstream map
kinase cascades including p38 Mapk, and Ikk-α (Derynck and
Zhang, 2003).
Tgfb3 is strongly and speciﬁcally expressed in the MEE (Fitzpatrick
et al., 1990; Pelton et al., 1990), and mouse embryos deﬁcient in Tgfb3,
as well as epithelium-speciﬁc Tgfbr1 or Tgfbr2 mutants suffer from
defective palatal epithelial fusion (Dudas et al., 2006; Kaartinen et al.,
1995; Proetzel et al., 1995; Xu et al., 2006). Xu et al. previously
showed that, at least in palatal explant cultures in vitro, Smad-
dependent (Smad4-mediated) and Smad-independent (p38Mapk-
mediated) pathways act redundantly during palatal epithelial fusion
(Xu et al., 2008). Here, we show that cooperation between different
TGF-β downstream mediators is even more extensive. By using
tissue-speciﬁc mouse mutants in conjunction with a whole-head
roller culture assay, we demonstrate that both Tak1:Smad4- and
Trim33:Smad4-double conditional mutants display speciﬁc palatal
fusion defects, and that simultaneous deletion/inactivation of all three
proteins in palatal epithelial cells results in palatal phenotypes
typically seen in epithelium-speciﬁc Tgfb3 mutants.
Experimental procedures
Mice
Tgfb3F, Tak1F IkkaF and Trim33F mice have been described earlier
(Doetschman et al., 2012; Kim and Kaartinen, 2008; Liu et al.,
2008; Yumoto et al., 2013). K14-Cre and Smad4F mice were
obtained from S. Millar (Andl et al., 2004) and C. Deng (Yang
et al., 2002), respectively. To generate mutant embryos, Cre-
positive male mice heterozygous for ﬂoxed (F) gene(s) were
crossed with female mice carrying corresponding homozygous
ﬂoxed allele(s) (see Table 1). For timed matings, the presence of a
vaginal plug was designated as embryonic day 0 (E0). DNA for
genotyping was prepared from tail tissues using DirectPCR lysis
reagents (Viagen Biotech). Mouse lines were maintained in mixed
genetic backgrounds. All experiments involving the use of animals
were approved by the Institutional Animal Use and Care Commit-
tee at the University of Michigan-Ann Arbor (Protocol
#00004320).
Histology, immunohistochemistry and cell death assays
Embryos were collected into sterile DPBS and ﬁxed at 4 1C
overnight in freshly prepared 4% paraformaldehyde in PBS. Sam-
ples used for wax embedding were washed, dehydrated through a
graded ethanol series (20, 50, 70, 95 and 100%) and an overnight
step in 50% Ethanol/50% Toluene, one hour step in 100% toluene,
one hour step in 50% toluene/50% fresh Blue Ribbon Tissue
Embedding/Inﬁltration Medium (Leica Surgipath) before being
oriented and embedded in fresh Blue Ribbon Tissue Embedding/
Inﬁltration Medium (Leica Surgipath) after three changes. Seven
μm sections (histology and immunohistochemistry) were cut,
mounted on Superfrost plus slides (Fisher) and stained with
hematoxylin and eosin according to standard protocols. Fusion%
was calculated as described by (Sun et al., 1998). Brieﬂy, the length
of conﬂuence was divided by total length of adherence and
multiplied by 100. For immunohistochemistry, sections were
rehydrated, and after antigen retrieval (5–20 min at 95–100 1C in
10 mM citrate buffer, pH6.0) proliferating cells were detected
using Ki67 antibody (#M7249; Dako). Cells positive for phos-
phorylated p38Mapk were detected using p-p38 Mapk antibody
(#4511; Cell Signaling). Antibody binding was visualized with
Alexa Fluor 594 secondary antibody (Life Technologies). Apoptotic
cells were detected using a TUNEL assay (Dead End, Promega)
following manufacturer's instructions. Fluorescent images were
viewed on an inverted ﬂuorescent Leica DMI3000B microscope
and documented using an Olympus DP72 camera.
In situ hybridization
Embryos were processed and embedded in parafﬁn as
described above. 10μm sections were cut and mounted on glass
slides. RNA probes were labeled using a DIG-labeled NTP mix
(Roche Applied Science) according to manufacturer's instructions,
stored at 80 1C and diluted in hybridization buffer. Section ISH
was performed as described (Moorman et al., 2001). After staining,
sections were ﬁxed and mounted in Immu-Mount (Thermo
Scientiﬁc). Probe templates for Tgfb3 and Mmp13 were prepared
as described (Blavier et al., 2001; Dudas et al., 2004).
Real-time quantitative PCR
Tissues were harvested from tips of palatal shelves from E14
and E15 mouse embryos, placed into 200 μl of RLT (RNeasy mini
kit, Qiagen), and RNAs were isolated by using RNeasy columns
(Qiagen). cDNAs were synthesized by using Omniscript reverse
transcriptase (Qiagen) according to the manufacturer's protocols.
Real time quantitative PCR experiments were done either by using
Universal Probe library-based assays (Roche Applied Science) or by
using TaqMan assay reagents (Applied Biosystems) (see Table 2).
30 μl assays were quantiﬁed using Applied Biosystems ABI7300
PCR and ViiA7 detection systems and software. Data were normal-
ized to β-actin mRNA levels using the 2ΔΔCt method.
Whole-head roller culture assays
Roller culture assays were modiﬁed from (Goudy et al., 2010).
Heads from E15 embryos were collected in DPBS and mandibles,
tongues, and brains were removed. The resulting mid-face samples
were cultured for 24 h at 37 1C in roller bottles (60 ml serum
bottles) (60 rotations/minute) in serum-free BGJb mediumwithout
penicillin and streptomycin. The bottles were gassed at the
Table 1
Crosses used to generate mutant embryos
Male Female
Tgfb3FWT:K14Creþ Tgfb3FF
Smad4WT:K14Creþ Smad4FF
Tak1FWTSmad4FWT:K14Creþ Tak1FFSmad4FF
IkkaFWTSmad4FWT:K14Creþ IkkaFFSmad4FF
Trim33FWTSmad4FWT:K14Creþ Trim33FFSmad4FF
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beginning of the culture and again every 12 h by gently bubbling
the medium for 2 min with O2/CO2 (95%/5%). The palatal cultures
were ﬁxed, sectioned and stained as described above. In 5Z-7-
oxozeanenol (Tak1 inhibitor; 10 μM; eMolecules) or SB202190
(p38 Mapk inhibitor; 10 μM; Sigma-Aldrich) treated samples, the
inhibitor was added directly into the culture medium.
Western-blot assays
Palatal shelf edges were removed and cultured as described
above in 2 ml cryovials (60 rotations/minute) at 37 1C in BGJb
medium for 1 h and then stimulated with TGF-β3 (10ng/ml)
(#243-B3-002; R&D Systems) for 40 min. Tissues were then
isolated and lysed in 2x Laemmli sample buffer, ran on NuPage
4–12% Bis-Tris gradient gels (Invitrogen) and transferred by “iBlot
dry blotting” (Invitrogen) onto nitrocellulose ﬁlters. Immunoblot-
ing and detection were done using standard protocols. The anti-
bodies used were p-38 Mapk (N-20) (#SC-728; Santa Cruz
Biotechnology) and p-p38 MapK (#4511; Cell Signaling).
Statistical analyses
For histological and real-time quantitative PCR analyses three or
more samples were analyzed. Averages, standard error and prob-
ability (Student's t-test, 2-tailed) were calculated. Probability
(p) equal or less than 0.05 was marked as statistically signiﬁcant (n).
Results
Epithelium-speciﬁc Smad4 mutants display mild defects in
palatogenesis
Smad-dependent and Smad-independent pathways have been
shown to play functionally redundant roles during palatal epithelial
fusion (Xu et al., 2008). To conﬁrm and expand these ﬁndings, we ﬁrst
compared palate phenotypes of epithelium-speciﬁc Tgfb3 mutants
(Tgfb3FF:K14-Cre¼Tgfb3-cKO) to those of corresponding Smad4-cKOs
(Smad4FF:K14-Cre). Tgfb3-cKOs display a fusion defect in the anterior
palate, failure of the anterior palate to fuse to the nasal septum,
variable degree of fusion in the mid-palate, persistent midline seam
and occasionally a cleft in the posterior palate (Fig. 1 A-F). These
observed phenotypes are less severe than those seen in Tgfb3 germline
mutants (Kaartinen et al., 1995; Proetzel et al., 1995), but are practically
identical to those seen in epithelium-speciﬁc Tgfbr1 and Tgfbr2
mutants (Dudas et al., 2006; Xu et al., 2006) suggesting that the
phenotypic difference between Tgfb3 germ line mutants and Tgfb3-cKO
results, at least in part, from the inability of K14-Cre to recombine in
the periderm as shown by (Lane et al., 2014). In contrast to phenotypes
seen in Tgfb3-cKOs, palatal phenotypes displayed by Smad4-cKOs were
very mild (Fig. 1G I, M and Table 3), yet consistent and previously
unappreciated (Xu et al., 2008). These include posterior epithelial
triangles and occasional failure of the anterior palate to fuse, and the
nasal septum to fuse to the anterior palate (1/4).
Simultaneous deletion of TGF-β activated kinase-1 and Smad4 results
in anterior and posterior palate defects
To further examine cooperation between Smad-independent
and Smad-dependent pathways during palatal epithelial fusion
in vivo, we generated an allelic series of double mutants lacking
one or both alleles of Tak1 (which, at least in some cell and/or
tissue types, is an upstream activator of p38 Mapk (Yamashita
et al., 2008)) and Smad4 in epithelial cells by crossing transgenic
K14-Cre male mice (Andl et al., 2004) that also were heterozygous
for both Tak1F and Smad4F alleles, with double homozygote
Tak1FFSmad4FF female mice (Table 3). Epithelium-speciﬁc Tak1
mutants (Supplementary Fig. 1) and double heterozygotes showed
no palatal phenotypes, while corresponding Tak1:Smad4 double
mutants (herein called Tak1:Smad4-dcKO) displayed speciﬁc and
consistent defects in palatogenesis (Fig. 1J L, M, and Table 3), e.g.,
persistent epithelial seam, anterior fusion defect and a failure of
the nasal septum to fuse to the anterior secondary palate. Cre-
positive embryos heterozygous for the ﬂoxed Tak1 allele and
homozygous for the ﬂoxed Smad4 allele showed similar but milder
defects as the dcKOs with variable penetrance (Table 3).
Additional modiﬁers of TGF-β signaling during palatal epithelial
fusion
Our results suggested that Tak1 plays a redundant regulatory
role in TGF-β signaling, perhaps by functioning upstream of
p38Mapk in palatal epithelial cells. Yet, the Tak1:Smad4-dcKO
palatal phenotypes (Fig. 1J L) were noticeably less severe than
those seen in corresponding Tgfb3-cKOs (Fig. 1D F) or Tgfbr1-cKOs
(Dudas et al., 2006)). Therefore we wondered whether, in addition
to the Tak1-mediated pathway, other signaling mediators could be
involved in TGF-β3-induced palatal epithelial fusion. As candi-
dates, we chose Ikk-α (Chuk) and Trim33 (Tif1γ; ectodermin),
because both proteins have been shown to be able to modulate
TGF-β signaling both by Smad-dependent and Smad-independent
mechanisms contingent on the biological context (He et al., 2006;
Liu et al., 2008). Our results showed that epithelium-speciﬁc single
mutants (i.e., Ikka-cKOs and Trim33-cKOs) did not show palatal
phenotypes (Supplementary Fig. 1, and data not shown), and that
Ikka:Smad4-dcKO mutant palates did not signiﬁcantly differ from
those of Smad4-cKOs (Fig. 2A F,M) suggesting that Ikk-α does not
contribute to TGF-β-triggered MEE removal. However, Trim33:
Smad4-dcKO mutants consistently showed a persistent midline
epithelial seam both in the anterior and in the posterior palate,
Table 2
Real-time quantitative PCR
Q-RTPCR using the universal probe system (Roche)
Gene Forward sequence Reverse sequence Universal probe (Roche)
Cytokeratin 14 (K14) atcgaggacctgaagagcaa tcgatctgcaggaggacatt #83
Tp63 (delta N p63) ggaaaacaatgcccagactc aatctgctggtccatgctgt #45
Cdkn1a (p21) cagatccacagcgatatcca ggcacactttgctcctgtg #21
Q-RTPCR using the TaqMan approach (Life Technologies)
Gene TaqMan reference (Life technologies)
Irf6 Mm00516797_m1
Mmp13 Mm00439491_m1
Cdkn2a (p16) Mm00494449_m1
Cdkn1c (p57) Mm01272135_g1
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and between the nasal septum and the anterior palate (Fig. 2G L,M
and Table 4). This phenotype differs from that seen in Smad4-cKOs
or in Tak1:Smad4-dcKOs (compare Figs.1 and 2) suggesting that
Trim33 and Smad4 cooperate in palatal epithelial fusion that are at
least in part distinct from that of a combined role of Tak1
and Smad4.
Expression of a TGF-β signaling target Mmp13 is affected in Tak1:
Smad4- and Trim33:Smad4 -double conditional mutants
It has been previously shown that Mmp13 expression is rapidly
induced by TGF-β3-signaling in the midline seam during palatogen-
esis (Blavier et al., 2001; Xu et al., 2006). To analyze whether Tak1
and Smad4- or Trim33 and Smad4-mediated pathways are involved
in regulation of Mmp13 expression, we ﬁrst harvested palatal
shelves from control, Tgfb3-cKO, Smad4-cKO, Tak1:Smad4-dcKO and
Trim33:Smad4-dcKO embryos at E15.0 and used qRT-PCR to quantify
their Mmp13 mRNA levels. As shown in Fig. 3A, Mmp13 expression
was signiﬁcantly reduced in Tgfb3, Tak1:Smad4-dcKO and Trim33:
Smad4-dcKO samples, while the reduction in Smad4-cKO samples
was rather modest and not statistically signiﬁcant (Fig. 3A). We also
used section ISH to analyzeMmp13 and Tgfb3 expression in the MES
and nasal septal epithelium (Fig. 3B–I). Cre-negative control and
Smad4-cKO samples displayed strong Tgfb3 and Mmp13 expression
both in the MES and in the nasal septal epithelium. In Tak1:Smad4-
dcKOs there was a notable reduction inMmp13 expression, while in
Trim33:Smad4-dcKOs Mmp13 expression was barely detectable. In
both samples, Tgfb3 mRNA levels did not differ from those seen in
controls. These results suggest that a known TGF-β signaling target
Mmp13 is regulated both by Tak1:Smad4- and Trim33:Smad4-
mediated pathways in palatal medial edge epithelial cells.
Altered gene expression in TGF-β pathway mutants
Iwata et al. recently reported that signaling through TgfβRII
stimulates Irf6 expression, which in turn suppresses dNp63 allow-
ing appropriate p21 (Cdkn1a, p21Cip1) expression (Iwata et al.,
2013). In prefusion palatal shelves at E14, we could not detect any
differences in Irf6 or dNP63 expression levels between the control,
Tgfb3-cKO, Smad4-cKO, Tak1:Smad4-dcKO or Tak1:Smad4-dcKO
Fig. 1. Epithelium-speciﬁc deletion of Tgfb3, Smad4 and Tak1 together with Smad4 results in defects in palatogenesis. Frontal sections (E18.0) on the anterior level (A, D, G, J),
mid anterior (B, E, H, K) and posterior (C, F, I, L) levels (see N for levels of sections along the anterior-posterior axis). A-C, Control; D-F, Tgfb3-cKO, G-I, Smad4-cKO, J-L, Tak1:
Smad4-dcKO. Asterisks in A, B, C, G illustrate the palatal mesenchymal conﬂuence, black arrows in D and J point to the sites of failed fusion in the anterior palate, black arrows
in E and K point to a gap between the nasal septum and the secondary palate, the black arrow in F points to an epithelial bridge in the posterior palate and black arrowheads
in H, I, K and L point to persistent epithelial seams. Scale bar, 200 μm. Bar graph (M) illustrates the degree of fusion (mesenchymal conﬂuence); Error bars, SEM; *, po0.05;
Ant, anterior level; Post, posterior level; NS, fusion between the nasal septum and secondary palate. N, mouse mouth roof at E18; superior view; red lines illustrate the levels
of frontal sections shown in A-L (n¼3).
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samples (Fig.3J). In the fusing palatal shelves at E15, Irf6 was
reduced only in Tak1:Smad4-dcKO samples, while dNP63 levels
were increased in Tgfb3- and Smad4-cKO samples. In contrast to
the lack of differences in Irf6 and dNP63 expression at E14, p21
expression levels were reduced in all samples lacking Smad4 (i.e.,
Smad4-cKO, Tak1:Smad4-dcKO and Trim33:Smad4-dcKO),but not in
Tgfb3-cKO samples (Fig. 3J). In addition to p21, TGF-β signaling has
been shown to regulate expression of other cyclin-dependent
kinase inhibitors in the MEE (Iordanskaia and Nawshad, 2011).
Therefore, we compared expression levels of p15 (Cdkn2b,
p15Ink4b), p16 (Cdkn2a, p16Ink4a) and p57 (Cdkn1c, p57Kip2) as
outlined above (Fig. 3K and data not shown). At E14, p16 expression
was signiﬁcantly reduced in Tgfb3-cKOs and in Tak1:Smad4-dcKOs,
but not in Trim33:Smad4-dcKOs, whereas Tgfb3-cKO samples
showed a dramatic increase in p57 expression at E15 (expression
levels of p15 were very low and did not show detectable differences
between controls and different mutants; data not shown). Taken
together, differences in expression level of candidate genes between
Tak1:Smad4-dcKOs and Tgfb3-cKOs suggest that Tak1 and TGF-β3
can affect, at least, in part distinct pathways that act together to
promote palatal epithelial fusion. Similarly, differences in gene
expression between Trim33:Smad4 and Tak1:Smad4 double mut-
ants imply that these molecules mediate distinct arms of TGF-β
signaling.
Epithelial cell proliferation and apoptosis are variably affected in
Tak1:Smad4- and Trim33:Smad4-dcKOs
Previous studies showed that TGF-β signaling in the palatal
epithelium induces cell cycle arrest that is a prerequisite for the
disappearance of the midline seam by apoptosis and other possible
mechanisms (Cui et al., 2003; Iwata et al., 2013; Nawshad, 2008). To
examine whether cell proliferation in the MES was affected in Tak1:
Smad4- or Trim33:Smad4-dcKOs, we used Ki67 immunostaining on
anterior frontal sections obtained from control (Cre-negative) and
dcKO embryos at E14.5 – E15.0 (Fig. 4A C). Both Tak1:Smad4- and
Trim33:Smad4-dcKOs showed an increased number of positively
staining epithelial cells in the tip of the nasal septum and in epithelial
tips of prefusion palatal shelves when compared to the controls
(Fig. 4A–C, J). In contrast, the number of TUNEL-positive apoptotic
cells was signiﬁcantly reduced in the control and mutant samples in
the anterior palate on the level of the nasal septum (Fig. 4D, F, H). MEE
cells of Tak1:Smad4-dcKOs showed reduced phosphorylation (activa-
tion) of apoptosis-associated TGF-β-induced signaling molecule p38
Mapk, while Trim33:Smad4-dcKOs did not demonstrate comparable
changes (Fig. 4 E, G, I).
Inactivation of Tak1 in Trim33:Smad4-dcKOs phenocopies the palate
defects seen in Tgfb3-cKOs
As outlined above, the palatal phenotypes of both Tak1:Smad4- and
Trim33:Smad4-dcKOs, while consistent and clear, were still less severe
than those seen in Tgfb3-cKOs. Therefore, we wondered whether
combined loss of Tak1, Smad4 and Trim33 would result in palatal
phenotypes similar to those seen in Tgfb3-cKOs. To this end, we used a
potent Tak1 inhibitor, 5Z-7-oxozeaenol, in conjunction with Trim33:
Smad4-dcKOs ex vivo by using a whole-head roller culture assay.
Control cultures treated with 5Z-7-oxozeaenol, which efﬁciently
blocked p38 Mapk phosphorylation (Fig. 5I), showed consistent and
reliable fusion identical to that seen in untreated cultures (Fig. 5A D).
Furthermore, Smad4-cKO cultures did not demonstrate detectable
phenotypes, and with addition of Tak1 inhibitor resembled the Tak1:
Smad4-dcKO phenotype (Supplementary Fig. 2). Under similar culture
conditions, Trim33:Smad4-dcKOs without the Tak1 inhibitor showed a
persistent midline seam both in the anterior and posterior palate,
comparable to that seen in Trim33:Smad4-dcKOs in vivo (Fig. 5E,F).
Table 3
Summary of palatal defects in Tgfb3, Smad4, Tak1 cKOs and Tak1:Smad4-dcKOs (E18.0).
Table III. Summary of palatal defects in Tgfb3, Smad4, Tak1 cKOs and
Tak1:Smad4-dcKOs (E18.0).
Genotype
Anterior Cleft/
Persistent
seam
Nasal Septum
Fusion Defect/
persistent seam
Posterior Midline
Seam/epithelial
triangle
Posterior
Cleft
Control (Cre -); n=3 0/3 0/3 0/3 0/3
Tgfb3FFK14-Cre; n=3 3/3 3/3 2/3 1/3
Smad4FFK14-Cre+; n=3 1/4 1/4 4/4 0/4
Tak1FFK14-Cre+; n=3 0/3 0/3 0/3 0/3
Tak1FWTSmad4FFK14-Cre+; n=3 1/3 2/3 2/3 0/3
Tak1FWTSmad4FWTK14-Cre+;n=3 0/3 0/3 0/3 0/3
Tak1FFSmad4FFK14-Cre+; n=3 4/4 4/4 4/4 1/4
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However, treatment of double-cKO cultures with the Tak1 inhibitor
resulted in palatal phenotypes practically identical to those seen in
Tgfb3-cKOs, i.e., an anterior hole and a posterior epithelial bridge
(Fig. 5G,H). These data suggest that Tak1, Smad4 and Trim33 are
redundantly transducing TGF-β3 signaling to remove the midline
epithelial seam, and to facilitate palatal anterior and posterior fusion
during palatogenesis (Fig. 6).
Discussion
Palatogenesis is a complex developmental process involving
appropriate growth, elevation and fusion of palatal shelves
(Ferguson, 1988). While the role of TGF-β3 in the palatal epithelium
(MEE) is well-established (Kaartinen et al., 1995; Proetzel et al.,
1995), recent studies have shown that mechanisms by which the
Fig. 2. Simultaneous deletion of Trim33 and Smad4 in epithelial cells leads to persistence of the midline seam. Frontal sections (E18.0) on the anterior level (A, D, G, J), mid
anterior (B, E, H, K) and posterior (C, F, I, L) levels (see Fig. 1N). A-C and G-I, Control; D-F, Ikka:Smad4-dcKO, J-L, Trim33:Smad4-dcKO. Asterisks in A, B, C, D, E, G, H, I illustrate
the palatal mesenchymal conﬂuence, black arrowheads in E point to epithelial islands between the nasal septum and the posterior palate, arrowhead in F points to the
persistent oral epithelial angle and black arrows in J, K, and L point to persistent epithelial seams. Scale bar, 200 μm. Bar graph (M) illustrates the degree of fusion
(mesenchymal conﬂuence); Error bars, SEM; *, po0.05; Ant, anterior level; Post, posterior level; NS, fusion between the nasal septum and secondary palate (n¼3).
Table 4
Summary of palatal defects in Ikka- and Trim33-cKOs and Ikka:Smad4- and Trim33:Smad4-dcKOs (E18.0).
Genotype Anterior cleft/ Persistent
seam
Nasal septum fusion defect/ Persistent
seam
Posterior midline seam/Epithelial
triangle
Posterior
cleft
Control (Cre -); n¼3 0/3 0/3 0/3 0/3
IkkaFFK14-Creþ ; n¼3 0/3 0/3 0/3 0/3
Trim33FFK14-Creþ ; n¼3 0/3 0/3 0/3 0/3
IkkaFFSmad4FFK14-Creþ ; n¼3 0/3 1/3 2/3 0/3
Trim33FFSmad4FFK14-Creþ ; n¼3 3/3 2/3 2/3 1/3
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downstream signaling is transduced are surprisingly complicated,
involving redundantly acting canonical and non-canonical arms of
TGF-β signaling (Iwata et al., 2013; Xu et al., 2008). Here we show
that in MEE cells, redundancy of TGF-β signal transduction is even
more extensive, since recapitulation of the Tgfb3-cKO palatal phe-
notype required inactivation of three separate genes/gene products
(Tak1, Smad4, Trim33) mediating different arms of TGF-β signaling.
Developing palatal shelves are composed of the mesenchyme
(largely derived from the cranial neural crest with a minor
contribution coming from the cranial paraxial mesoderm) and
from the ectoderm-derived surface epithelium, which is covered
by a thin layer of peridermal cells (Lane and Kaartinen, 2014).
Recent studies have shown that peridermal cells play a key role in
palatal shelf adherence, and that this layer has to be removed for
normal palatal adhesion and fusion to take place (Wu et al.,
2013a). Tgfb3 is expressed in both cell types (Lane et al., 2014)
and interestingly, the cleft palate phenotype of Tgfb3 null mutants
can be partially rescued by transducing Tgfb3 exclusively in
peridermal cells (Wu et al., 2013a). Likewise, Tgfb3-cKO mice,
which lack Tgfb3 in epithelial cells including the MEE but not in
peridermal cells, display signiﬁcantly milder palatal phenotypes
than those seen in systemic Tgfb3 mutants ((Lane et al., 2014) and
the present study), suggesting that TGF-β3 signaling is important
for peridermal cell removal and is thus required for adhesion and
fusion between the palatal shelves in the mid-palate. In fact, Tgfb3-
cKO palatal phenotypes are practically identical to those seen in
epithelium-speciﬁc Tgfbr1 or Tgfbr2 mutants (Dudas et al., 2006;
Xu et al., 2006). Moreover, this distinct palatal phenotype can be
seen in mice expressing Tgfb1 in the Tgfb3 locus (Yang and
Kaartinen, 2007) suggesting that Tgfb1 can functionally replace
Tgfb3 in peridermal cells but not in MEE cells. Nevertheless, the
consistent defects of Tgfb3-cKO embryos in the anterior and
posterior palate (anterior hole, nasal septum fusion defect and
posterior epithelial bridge/submucous cleft) show that TGF-β3-
mediated signaling is also crucial in the MEE, and that the K14-Cre
driver line is a useful tool to study gene functions in this cell type
during palatogenesis.
A previous study on epithelium-speciﬁc Tgfbr2:K14-Cre mice
suggested that TGF-β through TgfbRII triggers a Smad4-Irf6 signaling
cascade, which downregulates dNP63 resulting in p21 induction, cell
cycle arrest and removal of MEE cells (Iwata et al., 2013). Using the
same K14-Cre transgenic line (Andl et al., 2004) we demonstrate that
Tgfb3-cKO embryos, which display clear and consistent palatal defects
similar to those seen in Tgfbr2:K14-Cre mutants, do not show
differences in p21 expression in prefusion or fusing palatal shelves.
In addition, Smad4-cKOs, which display a very mild phenotype in the
posterior palate, consistently show reduced levels of p21 expression.
Based on these results we conclude that changes in p21 expression
are not causally related to the observed palatal phenotypes. Despite
the obvious reduction in p21 expression in Smad4-cKOs as well as in
Tak1:Smad4- and Trim33:Smad4-dcKOs, we could not see signiﬁcant
differences in Irf6 or dNP63 expression in prefusion palatal shelves at
E14. In fusing palatal shelves at E15, Tak1:Smad4-dcKOs palatal
shelves showed reduction in Irf6 expression while palatal tissues
harvested from Tgfb3-cKOs at E15 showed an increase in dNP63.
Whether these discrepancies between our current ﬁndings and those
Fig. 3. Gene expression differences in prefusion and fusing palatal shelves between controls and TGF-β pathway mutants. A, QRT-PCR analysis ofMmp13 expression in palatal
tissues of control (blue), Tgfb3cKO (red), Smad4-cKO (green), Tak1:Smad4-dcKO (purple) and Trim33:Smad4-dcKO (turquoise) at E15 (Error bars, SEM; *, po0.05, n43 or
more). B-I, In situ hybridization for Tgfb3 (B, C, D, E) and for Mmp13 (F, G, H, I). B, F, Control; C, G, Smad4-cKO; D, H, Tak1:Smad4-dcKO; E, I, Trim33:Smad4-dcKO. Frontal
sections of E15 embryos; anterior level. Scale bar in I, 100μm (for B-I). J, QRT-PCR analysis of Irf6, dNP63 and p21 expression in palatal tissues from control, Tgfb3-cKO, Smad4-
cKO, Tak1:Smad4-dcKO and Trim33:Smad4-dcKO embryos harvested at E14 and E15 (Error bars, SEM; *, po0.05, n43). K, QRT-PCR analysis of p16, and p57 expression in
palatal tissues from control, Tgfb3-cKO, Smad4-cKO, Tak1:Smad4-dcKO and Trim33:Smad4-dcKO embryos harvested at E14 and E15 (Error bars, SEM; *, po0.05; n43).
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reported by others (Iwata et al., 2013) are caused by experimental
variables, e.g., timing and/or technique of tissue harvest and differ-
ences in genetic backgrounds, or whether they are caused by other
currently unknown causes, remains to be shown.
In epithelial cells, TGF-βs are well-known growth inhibitory
cytokines (Siegel et al., 2003). It has been suggested that inhibition
of MEE proliferation by TGF-β signaling triggers a cascade of
events that results in the removal of MEE through apoptosis
(and to some extent by transdifferentiation/migration) (Cui et al.,
2003; Iwata et al., 2013; Nawshad, 2008). Despite some differences
in gene expression patterns between Tak1:Smad4-dcKOs and
Trim33:Smad4-dcKOs, we show that both of these epithelium-
speciﬁc double mutants show increased levels of proliferation,
particularly in the epithelial tips of the nasal septum, while a
smaller number of TUNEL-positive nuclei could be seen both in the
epithelial tips of palatal shelves and nasal septum. Increased cell
proliferation is consistent with our ﬁnding that p21 expression
levels are reduced in both dcKOs. However, it is likely that
expression of other negative cell cycle regulators, e.g., p16, is also
regulated by TGF-β, as p21 expression levels are not reduced in
Tgfb3 mutants, although they display a well-documented failure to
suppress cell proliferation in the prefusion MEE (Cui et al., 2003;
Dudas et al., 2004; Martinez-Alvarez et al., 2000).
A role of Tak1 in regulation of TGF-β3-induced p38Mapk
activation is currently controversial. Several studies have sug-
gested that Traf6-Tak1 signaling module mediates TGF-β-induced
p38Mapk activation (Kim et al., 2009; Sorrentino et al., 2008;
Yamashita et al., 2008), while other studies have proposed that
instead of Tak1, other Map3Ks, e.g., Map3K4 and Map3K10, play
the key role in transducing TGF-β signaling that results in p38
Mapk phosphorylation (Sapkota, 2013). We previously showed
that neural crest-derived ectomesenchymal cells lacking Tak1 fail
to demonstrate TGF-β-induced p38 Mapk activation (Yumoto et
al., 2013). Our present results imply that also in MEE cells Tak1 is
at least partially responsible for mediating p38 Mapk activation,
since we could see reduction in p38Mapk phosphorylation in Tak1:
Smad4-dcKOs when compared to controls or Trim33:Smad4-dcKOs.
Moreover, similar to palatal explant cultures with inactivated p38
Fig. 4. Proliferation and cell death are affected in Tak1:Smad4 and Trim33:Smad4-dcKOs. Immunostaining for Ki67 (red) in control (A, A’), Tak1:Smad4- (B, B’) and Trim33:
Smad4-dcKO (C, C’) at E14.5-E15. Frontal sections, anterior level. Counterstaining with DAPI (blue nuclei). In A, B and C palatal shelves are forming a contact with each other,
and in A’, B’ C’ the midline seam is forming. White arrowheads in A-C point to Ki67-positive cells in the MEE and nasal septum epithelium. TUNEL staining to detect
apoptotic/necrotic cells (white arrows in D, F, H; green nuclei) in control (D), Tak1:Smad4:dcKOs (F) and in Trim33:Smad4-dcKO(H) samples (E15.0). Frontal sections, anterior
level; counter staining with DAPI (blue). Immunostaining for phosphorylated p38 Mapk (p-p38, red staining) in control (E), Tak1:Smad4:dcKOs (G) and in Trim33:Smad4-dcKO
(I) samples (E15.0). White arrows in E, G, and I point to positively-staining cells. Frontal sections, anterior level; counter staining with DAPI (blue). Scale bar in A, 50 μm (for
A-I). J, Bar graph shows quantiﬁcation of proliferation (Ki67, positively staining cells both in the nasal septum and MEE were counted) apoptosis (TUNEL) and phopho-p38
Mapk assays (Error bars, SEM; *, po0.05; n43).
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Mapk, inactivation of Tak1 alone, which totally abolished the
p38Mapk phosphorylation (Fig. 5I), did not result in defects in
palatogenesis (Fig. 5), while simultaneous inactivation of Tak1 and
deletion of Smad4 in explant cultures resulted in palatal pheno-
types similar to that seen in Tak1:Smad4-dcKOs in vivo
(Supplementary Fig. 1). In the roller culture assay, Tak:Wnt1-Cre
mutant palatal shelves were able to go through normal palatogen-
esis (Yumoto et al., 2013) suggesting that lack of Tak1 in the palatal
mesenchyme does not alter the ability of the palatal shelves to go
through normal fusion. In our study, the Tak1 inhibitor was added
at the time of palatal shelf adhesion and does not cause visible
phenotypes within the mesenchyme that would alter the way
analysis is done in the presence of a persistent epithelial seam. In
addition, upon simultaneous inactivation of Tak1 and deletion of
Smad4 in the roller culture system, we see a palatal phenotype
similar to that seen in Tak1:Smad4-dcKOs in vivo. The Tak1
inhibitor 5Z-7-oxozeaenol also inhibits several other protein
kinases when tested with a kinase panel (Wu et al., 2013b), and
therefore we cannot fully exclude a possibility that (in addition to
Tak1), inactivation of other protein kinases would be partially
responsible for p38 Mapk inhibition and for the observed palate
phenotypes in the roller culture system. However, notable simila-
rities between Tak1 mutant palate phenotypes in vivo and corre-
sponding phenotypes in inhibitor-treated samples in vitro (as
shown above), together with the ﬁnding that the inhibitor displays
remarkable speciﬁcity in inhibition of Tak1 pathway in cell lines
(Wu et al., 2013b), alleviate these concerns.
Mutations in the IRF6 gene cause van der Woude syndrome, an
autosomal dominant syndrome characterized by cleft lip and/or
palate (Kondo et al., 2002). Mouse embryos lacking Irf6 display early
differentiation defects of the ectoderm, which are practically
Fig. 5. Conditional removal of Trim33 and Smad4 along with Tak1 inhibition recapitulates the palatal phenotype seen in Tgfb3-cKO embryos. A whole-head roller culture
assay of Cre-negative controls (A-D) and Trim33:Smad4-dcKOs (E-H) in the absence (A,B, E, F) and presence of Tak1 inhibitor (C, D, G, H). A, C, E, G, frontal sections, anterior
level; B, D, F, H, frontal sections, posterior level. Asterisks in A, B, C, D illustrate mesenchymal conﬂuence, black arrow in D points to oral epithelial triangle, black arrows in E
point to intact MEE cells in palatal shelves and nasal septum, black arrow in F points to the persistent epithelial seam, black arrows in G point to the anterior cleft and black
arrow in H points to the posterior epithelial bridge. Scale bar, 100μm. I, Tak1 inhibitor 5Z-7-oxozeaenol (5Z) prevents p38 Mapk phosphorylation in palatal shelves harvested
from whole-head roller cultures. J, bar graph shows degree of palatal fusion in control and Trim33:Smad4-cKO samples cultured in the presence or absence of 5Z in a whole-
head roller culture assay. Error bars, SEM; *, po0.05; n¼3). Blue columns, anterior palate; red columns, posterior palate. 0% fusion represents a full cleft or the presence of a
fully intact epithelial seam.
Fig. 6. Schematic drawing illustrating cooperation between Tak1, Smad4 and
Trim33 during palatal epithelial fusion. MEE, medial edge epithelium; MES,
midline seam.
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identical to those seen in Ikka knockout mice (Ingraham et al., 2006;
Liu et al., 2008; Richardson et al., 2006). Therefore, it is surprising
that deletion of Ikka in epithelial cells including the MEE does not
result in noticeable defects in palatogenesis. Instead, we discovered
that in MEE cells, concomitant deletion of a novel chromatin reader
Trim33 and Smad4 led to defective palatal fusion. Several recent
reports have demonstrated that epigenetic mechanisms involving
appropriate histone modiﬁcations are crucial for successful cranio-
facial development and palatogenesis. In humans, haploinsufﬁ-
ciency of histone-3 demethylases, e.g., PHF8 and KATB6, has been
shown to result in cleft palate (Clayton-Smith et al., 2011;
Laumonnier et al., 2005), while neural crest speciﬁc deletion of
Hdac3 resulted in severe craniofacial defects including cleft palate in
mouse embryos (Singh et al., 2013). Trim33 is a multifunctional
protein (Dupont et al., 2005), which has been shown to both
facilitate and antagonize TGF-β signaling. In differentiating stem
cells, Trim33, when complexed with Smad2, is able to bind to
speciﬁc poised chromatin marks found in the promoter regions of
master regulators, rendering them accessible to R-Smad/Co-Smad
complexes (Xi et al., 2011). In other cellular systems, Trim33 has
been shown to mono-ubiquitinate Smad4 disrupting Smad4-
chromatin complexes and limiting their residence time at TGF-β-
responsive enhancers (Agricola et al., 2011; Dupont et al., 2009).
Here we show that in MEE cells Trim33 does not function as a
negative regulator of canonical TGF-β signaling, but rather that
Trim33 and Smad4 are functionally redundant during palatal fusion
(Fig. 6). A similar redundant role of Smad4 and Trim33 in control of
neural stem cell proliferation was recently shown to take place in
the developing cortex (Falk et al., 2014).
In conclusion, our data indicate that complex and largely
redundant mechanisms involving both non-canonical and canoni-
cal arms of TGF-β signaling control disappearance of MEE cells
during palatal fusion. These involve Tak1, Smad4 and a novel
Smad2 binding partner and a putative chromatin reader Trim33
(Fig. 6). While the roles of Tak1 and Trim33 appear fully redundant
with Smad4, our results also reveal a subtle but consistent, and
previously unappreciated, non-redundant role for Smad4 in MEE
cells during palatogenesis.
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